SignalChem enters a clinical trial collaboration with Merck to evaluate the effect of SLC-391 in combination with KEYTRUDA® (pembrolizumab) in advanced non-small cell lung cancer
March 25, 2021
March 25, 2021
March 8, 2021
December 21, 2020
December 10, 2020
October 22, 2020
October 14, 2020
July 7, 2020
June 25, 2020
June 11, 2020
June 1, 2026
Designed to adapt to diverse biopharma development needs, and enabled by close collaboration and parallel execution, the partnership introduces a flex...
June 1, 2026
Spectronaut 21 (DIA) and SpectroMine 6 (DDA): cloud-enabled processing, increased identifications, enhanced PTM identification and site localization c...
May 28, 2026
Version 1.0 strengthens the fast, confident HDX-MS analysis experience with workflow-focused enhancements, optimized performance, and improved support...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225